...
SCLXSMALL

Scilex Holding Company

HealthcareDrug Manufacturers - General
$8.21
$0.00(+1.11%)
52W$3.60
$34.27
FinancialsValuationvs ABBV
Updated Mar 1, 12:00 AM
RSI36
RS Rating19/99
Beta0.96
Volatility127%
F-Score6/9
Mkt Cap$1.5B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Scilex Holding Company is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 19), showing significant lag compared to the market leaders. Earnings contraction of 17% provides fundamental context to the price action. Investors should exercise caution due to high volatility (127% annualized), which requires wider risk management.

Relative Strength
19
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.96
vs S&P 500
MARKET
52W Position
15%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$10.73
50 SMA > 100 SMA$14.10
100 SMA > 150 SMA$16.15
150 SMA > 200 SMA$13.65

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$8.37-1.89%BELOW
50 SMA$10.73-23.47%BELOW
100 SMA$14.10-41.76%BELOW
150 SMA$16.15-49.18%BELOW
200 SMA$13.65-39.87%BELOW

Price Performance

1D+1.1%
1W+4.6%
1M-7.2%
3M-59.7%
6M-55.0%
YTD-37.3%
1Y-0.6%
3Y-70.0%
52-Week Trading Range15% from low
$8.21
52W Low$3.60
52W High$34.27

Technical Indicators

RSI (14)BEARISH
35.9
305070
VCP ScoreCOOL
5/10
Base depth: 157.6%

Risk Profile

Beta
0.96
52W Vol
127%
ATR
$0.63
Max DD (1Y)
-74%

Volume Analysis

Today
8
50D Avg
60.8K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+84%
$-1.23
Q1'25+66%
$-2.26
Q2'25+32%
$-7.42
Q3'25-1732%
$-22.17
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:—
3 Years:+21.80%
TTM:-26.82%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:-25.64%

Stock Price CAGR

10 Years:-31.18%
5 Years:-52.64%
3 Years:-69.96%
1 Year:-0.61%

Return on Equity

10Y Avg:-64.5%
5Y Avg:-64.5%
3Y Avg:-64.5%
Last Year:—

Key Metrics

Market Cap$1.5B
Gross Margin70.5%
Net Margin-1.3%
Piotroski F-Score6/9

More SCLX Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

SCLX vs ABBVABBVAMGNGILDNVO

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 19 meansSCLX outperformed 19% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.96 means 4% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is SCLX in an uptrend right now?

SCLX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is SCLX overbought or oversold?

SCLX's RSI (14) is 36. The stock is in neutral territory, neither overbought nor oversold.

Is SCLX outperforming the market?

SCLX has a Relative Strength (RS) Rating of 19 out of 99. SCLX is currently lagging the broader market.

Where is SCLX in its 52-week range?

SCLX is trading at $8.21, which is 24% of its 52-week high ($34.27) and 15% above its 52-week low ($3.60).

How volatile is SCLX?

SCLX has a Beta of 0.96 and 52-week volatility of 127%. It's less volatile than the S&P 500 - generally more stable.